Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis

media

posted on 2020-09-16, 16:06 authored by Stanley B. Cohen, Jeffrey D. Greenberg, James Harnett, Ann Madsen, Timothy W. Smith, David Gruben, Richard Zhang, Tatjana Lukic, John Woolcott, Kimberly J. Dandreo, Heather J. Litman, Taylor Blachley, Anne Lenihan, Connie Chen, Jose L. Rivas, Maxime Dougados

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).